• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童 COVID-19 肺炎中 I 型 IFN 免疫的隐性先天性缺陷。

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.

机构信息

St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.

Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.

出版信息

J Exp Med. 2022 Aug 1;219(8). doi: 10.1084/jem.20220131. Epub 2022 Jun 16.

DOI:10.1084/jem.20220131
PMID:35708626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9206114/
Abstract

Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated children, which is much lower than in unvaccinated adults, remains unexplained. In an international cohort of 112 children (<16 yr old) hospitalized for COVID-19 pneumonia, we report 12 children (10.7%) aged 1.5-13 yr with critical (7 children), severe (3), and moderate (2) pneumonia and 4 of the 15 known clinically recessive and biochemically complete inborn errors of type I IFN immunity: X-linked recessive TLR7 deficiency (7 children) and autosomal recessive IFNAR1 (1), STAT2 (1), or TYK2 (3) deficiencies. Fibroblasts deficient for IFNAR1, STAT2, or TYK2 are highly vulnerable to SARS-CoV-2. These 15 deficiencies were not found in 1,224 children and adults with benign SARS-CoV-2 infection without pneumonia (P = 1.2 × 10-11) and with overlapping age, sex, consanguinity, and ethnicity characteristics. Recessive complete deficiencies of type I IFN immunity may underlie ∼10% of hospitalizations for COVID-19 pneumonia in children.

摘要

I 型干扰素(IFN)先天性免疫的隐性或显性遗传缺陷可能导致未接种疫苗的成年人发生严重的 COVID-19 肺炎。而未接种疫苗的儿童患 COVID-19 肺炎的风险比未接种疫苗的成年人低得多,其原因仍不清楚。在一项针对 112 名因 COVID-19 肺炎住院的儿童(<16 岁)的国际队列研究中,我们报告了 12 名年龄在 1.5-13 岁的儿童患有严重(7 名)、重度(3 名)和中度(2 名)肺炎,其中 4 名患有已知的临床隐性和生化完整的 I 型 IFN 先天性免疫缺陷:X 连锁隐性 TLR7 缺陷(7 名)和常染色体隐性 IFNAR1(1 名)、STAT2(1 名)或 TYK2(3 名)缺陷。缺乏 IFNAR1、STAT2 或 TYK2 的成纤维细胞对 SARS-CoV-2 非常敏感。在 1224 名无肺炎的良性 SARS-CoV-2 感染儿童和成年人中(年龄、性别、血缘关系和种族特征重叠)未发现这些 15 种缺陷(P = 1.2×10-11)。I 型 IFN 免疫的隐性完全缺陷可能导致约 10%的儿童 COVID-19 肺炎住院病例。

相似文献

1
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.儿童 COVID-19 肺炎中 I 型 IFN 免疫的隐性先天性缺陷。
J Exp Med. 2022 Aug 1;219(8). doi: 10.1084/jem.20220131. Epub 2022 Jun 16.
2
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.Ⅰ型干扰素免疫基因罕见的预测性功能丧失变异与危及生命的 COVID-19 相关。
Genome Med. 2023 Apr 5;15(1):22. doi: 10.1186/s13073-023-01173-8.
3
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome.儿童重症 COVID-19 肺炎合并多系统炎症综合征伴固有型 IFNAR1 缺陷
J Clin Immunol. 2022 Apr;42(3):471-483. doi: 10.1007/s10875-022-01215-7. Epub 2022 Jan 28.
4
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.约 1%的 60 岁以下患有危及生命的 COVID-19 的男性存在 X 连锁隐性 TLR7 缺陷。
Sci Immunol. 2021 Aug 19;6(62). doi: 10.1126/sciimmunol.abl4348.
5
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.COVID-19 危重症患者的 I 型 IFN 免疫先天缺陷。
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
6
Human genetic and immunological determinants of SARS-CoV-2 infection and multisystem inflammatory syndrome in children.儿童感染严重急性呼吸综合征冠状病毒2及多系统炎症综合征的人类遗传和免疫决定因素。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae062.
7
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia.遗传性 MyD88 和 IRAK-4 缺陷的人类易患低氧血症性 COVID-19 肺炎。
J Exp Med. 2023 May 1;220(5). doi: 10.1084/jem.20220170. Epub 2023 Mar 3.
8
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs.通过两种类型的 I 型干扰素的先天缺陷来攻克危及生命的 COVID-19。
J Clin Invest. 2023 Feb 1;133(3):e166283. doi: 10.1172/JCI166283.
9
Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants.新型冠状病毒肺炎的人类基因组学:稀有和常见变异的贡献。
Annu Rev Biomed Data Sci. 2023 Aug 10;6:465-486. doi: 10.1146/annurev-biodatasci-020222-021705. Epub 2023 May 17.
10
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.I型干扰素免疫基因罕见的预测功能丧失变异与危及生命的新冠肺炎相关。
medRxiv. 2022 Oct 25:2022.10.22.22281221. doi: 10.1101/2022.10.22.22281221.

引用本文的文献

1
The impact of genetic immune disorders on infections including COVID-19, inflammatory bowel disease and cancer.遗传性免疫疾病对包括新冠病毒感染、炎症性肠病和癌症在内的感染性疾病的影响。
Nat Immunol. 2025 Jul 28. doi: 10.1038/s41590-025-02225-4.
2
Association Between Genetic Variants in , , and Genes and Severity of COVID-19: A Cross-Sectional Study of Patients from Southern Brazil.、和基因中的基因变异与 COVID-19 严重程度之间的关联:巴西南部患者的横断面研究。
Diagnostics (Basel). 2025 May 31;15(11):1403. doi: 10.3390/diagnostics15111403.
3
From Rare to Common: Genetic Insights into TLR7 Variants in a Multicentric Spanish Study on COVID-19 Severity.

本文引用的文献

1
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.携带 I 型干扰素自身抗体的患者感染 COVID-19 后死亡风险显著更高且与年龄相关。
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2200413119. doi: 10.1073/pnas.2200413119. Epub 2022 May 16.
2
A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes.在波利尼西亚,IFNAR1 失活等位基因导致纯合子中严重的病毒病。
J Exp Med. 2022 Jun 6;219(6). doi: 10.1084/jem.20220028. Epub 2022 Apr 20.
3
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic.
从罕见到常见:西班牙一项关于 COVID-19 严重程度的多中心研究中 TLR7 变体的遗传学见解
J Clin Immunol. 2025 May 27;45(1):100. doi: 10.1007/s10875-025-01892-0.
4
Type I interferon autoantibody footprints reveal neutralizing mechanisms and allow inhibitory decoy design.I型干扰素自身抗体足迹揭示中和机制并助力抑制性诱饵设计。
J Exp Med. 2025 Jun 2;222(6). doi: 10.1084/jem.20242039. Epub 2025 Mar 20.
5
Association Between Single-Nucleotide Polymorphisms in (), , and Genes with Severe Symptoms in Children Presenting COVID-19.新型冠状病毒肺炎患儿中()、、和基因单核苷酸多态性与严重症状之间的关联。 (注:原文括号处内容缺失)
Viruses. 2024 Dec 30;17(1):35. doi: 10.3390/v17010035.
6
The monogenic landscape of human infectious diseases.人类传染病的单基因格局。
J Allergy Clin Immunol. 2025 Mar;155(3):768-783. doi: 10.1016/j.jaci.2024.12.1078. Epub 2024 Dec 24.
7
Human coronaviruses: activation and antagonism of innate immune responses.人类冠状病毒:先天免疫反应的激活与拮抗
Microbiol Mol Biol Rev. 2025 Mar 27;89(1):e0001623. doi: 10.1128/mmbr.00016-23. Epub 2024 Dec 19.
8
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity.一种常见的显性人类干扰素α/β受体1(IFNAR1)缺陷形式会损害IFN-α和-ω介导的免疫,但不影响IFN-β依赖的免疫。
J Exp Med. 2025 Feb 3;222(2). doi: 10.1084/jem.20241413. Epub 2024 Dec 16.
9
Human DBR1 deficiency impairs stress granule-dependent PKR antiviral immunity.人类DBR1缺乏会损害应激颗粒依赖性PKR抗病毒免疫。
J Exp Med. 2025 Jan 6;222(1). doi: 10.1084/jem.20240010. Epub 2024 Dec 5.
10
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist.全基因组 CRISPR 敲除筛选发现 PLCSR1 是新冠病毒进入细胞的内在屏障,近期的病毒变异体已进化出抵抗该屏障的能力。
PLoS Biol. 2024 Sep 24;22(9):e3002767. doi: 10.1371/journal.pbio.3002767. eCollection 2024 Sep.
北极地区新型常染色体隐性 IFNAR2 缺陷导致危及生命的病毒性疾病。
J Exp Med. 2022 Jun 6;219(6). doi: 10.1084/jem.20212427. Epub 2022 Apr 20.
4
SARS-CoV-2 infections in children: Understanding diverse outcomes.儿童感染 SARS-CoV-2:了解不同的结果。
Immunity. 2022 Feb 8;55(2):201-209. doi: 10.1016/j.immuni.2022.01.014. Epub 2022 Jan 20.
5
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome.儿童重症 COVID-19 肺炎合并多系统炎症综合征伴固有型 IFNAR1 缺陷
J Clin Immunol. 2022 Apr;42(3):471-483. doi: 10.1007/s10875-022-01215-7. Epub 2022 Jan 28.
6
Human genetic and immunological determinants of critical COVID-19 pneumonia.人类遗传和免疫因素决定新冠肺炎重症肺炎。
Nature. 2022 Mar;603(7902):587-598. doi: 10.1038/s41586-022-04447-0. Epub 2022 Jan 28.
7
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients.Toll 样受体 7 中的罕见变异导致 COVID-19 患者细胞因子介导的信号转导功能障碍和下调。
Genes Immun. 2022 Feb;23(1):51-56. doi: 10.1038/s41435-021-00157-1. Epub 2021 Dec 24.
8
Mechanisms of viral inflammation and disease in humans.人类病毒炎症和疾病的机制。
Science. 2021 Nov 26;374(6571):1080-1086. doi: 10.1126/science.abj7965. Epub 2021 Nov 25.
9
SARS-CoV-2, COVID-19 and the Ageing Immune System.SARS-CoV-2、COVID-19 和衰老的免疫系统。
Nat Aging. 2021 Sep;1(9):769-782. doi: 10.1038/s43587-021-00114-7. Epub 2021 Sep 14.
10
Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis.儿童肠道病毒脑脊髓炎中 TLR3 或 MDA5 依赖性 I 型 IFN 免疫的先天缺陷。
J Exp Med. 2021 Dec 6;218(12). doi: 10.1084/jem.20211349. Epub 2021 Nov 2.